St. James Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$896K Buy
11,430
+1,594
+16% +$129K 1.64% 23
2022
Q3
$801K Sell
9,836
-269
-3% -$24.2K 1.75% 20
2022
Q2
$914K Sell
10,105
-26,064
-72% -$2.64M 1.85% 24
2022
Q1
$4.04M Buy
36,169
+5,738
+19% +$606K 3.23% 12
2021
Q4
$3.17M Buy
+30,431
New +$3.52M 2.34% 20

Other funds holding MDT

St. James Investment Advisors's MDT Position: Q4 2022 in Review

St. James Investment Advisors increased its Medtronic (MDT) stake by 16% in Q4 2022, buying an estimated $129K and bringing the position to 11,430 shares worth $896K. The position accounts for 1.64% of the portfolio, ranked #23.

St. James Investment Advisors first reported a position in MDT in Q4 2021 and has held it in 5 quarters since. The position peaked at $4.04M in Q1 2022. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • St. James Investment Advisors held 11,430 shares of Medtronic worth $896K as of Q4 2022.
  • St. James Investment Advisors bought 1,594 Medtronic shares in Q4 2022, an estimated $129K.
  • Medtronic made up 1.64% of St. James Investment Advisors's portfolio in Q4 2022, its #23 holding.
  • St. James Investment Advisors first reported a position in Medtronic in Q4 2021 and has held it in 5 quarters since.
  • St. James Investment Advisors's Medtronic position peaked at $4.04M in Q1 2022.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on St. James Investment Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.